Kamineni Oncology Centre Private Limited, a active private limited company, was established on 20 February 1998 in Hyderabad, Telangana, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85110TG1998PTC028936. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Gayatri Devi Kamineni (Additional Director), Bhargavi Kamineni (Director), Shashidhar Kamineni (Director). Past directors included Kamineni Suryanarayana, Bhargavi Kamineni. It holds ₹309.00 Cr open charges and ₹4.43 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5-9-111510 A, Kanchenjunda King Koti, Hyderabad, Telangana.
U85110TG1998PTC028936
028936
20 February 1998
₹1.00 Cr
₹0.15 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Kamineni Oncology Centre Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gayatri Devi Kamineni | Additional Director | 01 Apr 2025 | Current |
| Bhargavi Kamineni | Director | 18 Aug 2023 | Current |
| Shashidhar Kamineni | Director | 28 Feb 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Nov 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kamineni Oncology Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 218.15% increase. The company also saw a substantial improvement in profitability, with a 445.95% increase in profit. The company's net worth Soared by an impressive increase of 63.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kamineni Oncology Centre had a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,090,000,000.00
₹44,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2024 | Others | ₹309.00 Cr | Open |
| 29 Mar 2023 | Others | ₹4.43 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kamineni Oncology Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kamineni Oncology Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamineni Oncology Centre's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 309.00 Cr registered on 11 Nov 2024 with Charge ID 101011163 was modified on 14 Aug 2025. was completed.
The activity Gayatri Devi Kamineni was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 7 months 25 days . was completed.
A charge registered on 29 Mar 2023 via Charge ID 100710183 with Others was fully satisfied on 12 Dec 2024. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 309.00 Cr with Charge ID 101011163 was registered on 11 Nov 2024. was completed.
The activity Kamineni Oncology Centre Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Kamineni Oncology Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The Institute of Bone Marrow Transplantation is outfitted with state-of-the-art technology and specialised expertise to offer holistic care to patients grappling with both malignant and benign blood d.
The CIN of Kamineni Oncology Centre Private Limited is U85110TG1998PTC028936.
Kamineni Oncology Centre Private Limited is headquartered at 5-9-111510 A, Kanchenjunda King Koti, Hyderabad, Telangana.
Kamineni Oncology Centre Private Limited was incorporated on 20 February 1998.
The current directors of Kamineni Oncology Centre Private Limited are
The primary industry of Kamineni Oncology Centre Private Limited is Hospital And Medical Care.
Kamineni Oncology Centre Private Limited is unlisted.
The authorized capital of Kamineni Oncology Centre Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.15 M.
The compliance status of Kamineni Oncology Centre Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX